Lyncée Tec SA

Swiss Biotech Association

Not a member

Lyncée Tec SA is the reference company in the fields of 4D microscopy and Quantitative Phase Imaging. Its unique technology opens new quality control and research opportunities in micro-production, semi-conductor, micro-optics, watch industry, high content screening, and cell imaging.

http://www.lynceetec.com

Location

EPFL Innovation Park, 1015 Lausanne, Switzerland

Get Directions

Facts & figures

Type of organization

Private company
Year of foundation

2003
Number of employees in Switzerland

20-49

Key business

Core competencies

Platform technologies

You may also be interested in

Novochizol SA

Novochizol SA researches and develops applications of Novochizol, a unique chitosan nanoparticle technology that yields different carriers of small molecules, peptides, nucleic acids and proteins for sustained, localized delivery to any living tissue, with intracellular targeting potential.
1870 Monthey

Member

GlycoEra AG

GlycoEra leverages its control over natural glycan-mediated pathways to advance novel drugs using its propriety platform, the CustumGlycan Platform. GlycoEra develops first in class therapeutics in inflammatory disease, autoimmune disorder and immuno-oncology indications.
8952 Schlieren

Member

cellvie AG

cellvie is pioneering Therapeutic Mitochondria Transfer, a novel treatment approach aimed at the cellular energy metabolism. The technology's first application will be in ischemia-reperfusion injury, specifically in kidney transplantation. But the aim is to develop a broad platform.
9548 Matzingen

Member